Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Cervical Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
39 drugs · 148 active trials
4 drugs · 53 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 8 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Dordaviprone | Phase 1 | Phase 1 | 1 | 1 | 0 | 1 | 0 | — | — | Oct 23, 2023 |
| Elimusertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Aug 25, 2021 |
| Hyperthermic Intraperitoneal Chemotherapy | Phase 1 | Early Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jun 13, 2022 |
| Talazoparib | Phase 1 | Phase 1 | 1 | 1 | 0 | 1 | 0 | — | — | Sep 26, 2019 |
| Abemaciclib | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 12, 2019 |
| Abexinostat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Mar 31, 2021 |
| Alisertib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2013-08 |
| Brentuximab Vedotin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 29, 2020 |
| Buparlisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Sep 29, 2014 |
| Futibatinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Mar 24, 2023 |
| Infigratinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2015-01 |
| Margetuximab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 18, 2017 |
| Porcupine Inhibitor WNT974 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 1, 2011 |
| Vatalanib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2005-09 |
| Zoledronic Acid | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2005-04 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.